Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Planning for retirement at the right age is crucial for financial security. Discover how to choose the best age to start your retirement plan.
26,113 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Casey’s General Stores posted stronger fuel margins and a growing Rewards base, lifting investor optimism. Analysts c...
Moscow Exchange is set to publish an official XRP index as part of a broader crypto expansion that will also cover SO...
Remax Holdings posted a revenue decline and a sharper net loss in Q1 2026, while debt rose to $436 million. Real Brok...
A fresh Mizuho note raises Intel's price target to $124 on AI server demand, signaling renewed confidence in the turn...
Applied Materials is set to report Q2 results after the close, as investors weigh demand signals for AI chips and adv...
The Vatican has established a dedicated AI commission as Pope Leo XIV prepares a papal encyclical on AI ethics with A...
Rate Insurance's 2026 Trends Report shows 2025 home premiums rose 9.16%, the first notable slowdown after years of do...
In a speculative timeline, Kevin Warsh is named Federal Reserve Chair, prompting a rethink of policy amid AI-driven g...
The latest BEA data show the Fed's preferred inflation measure at a three-year high, signaling price pressures may pe...
Ford posted solid Q1 results with rising revenue and a booming software business, while GM delivered a robust earning...
As XRP and Cardano chase a $5 milestone, traders weigh price paths, ETF momentum, and a major Cardano upgrade set for...